medigraphic.com
SPANISH

Revista Médica Sinergia

Revista Médica Sinergia
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 07

<< Back

Revista Médica Sinergia 2023; 8 (07)

Migraine red flags: symptoms you shouldn't ignore

Aguilar HLM; González AFJ, Salazar PD
Full text How to cite this article

Language: Spanish
References: 15
Page:
PDF size: 148.09 Kb.


Key words:

migraine, red flags, headache, drugs, headaches, neurology.

ABSTRACT

Migraine is a common medical condition that affects millions of people around the world. Although in most cases migraine can be managed with medication and lifestyle changes, it is important to identify the red flags.
Migraine red flags are symptoms or warning signs that may indicate the presence of a more serious underlying cause in migraineurs. These symptoms are important to recognize as they may require further diagnostic testing to rule out other diseases or serious neurological disorders.
Among the types of migraine "red flags" are focal neurological symptoms, headaches of recent onset in the elderly, headaches that worsen with physical exertion, headaches associated with fever, among others.
It is important to note that, if migraine "red flags" occur, a neurology specialist should be seen for a complete evaluation and to determine if additional diagnostic tests are necessary. In this way, an accurate diagnosis can be established, and appropriate treatment provided for migraine and any other underlying conditions.


REFERENCES

  1. Munoz-Ceron J, Marin-Careaga V, Peña L, Mutis J, Ortiz G. Headache at the emergency room: Etiologies, diagnostic usefulness of the ICHD 3 criteria, red and green flags. PLoS One [Internet]. 2019 [citado el 15 abril 2023];14(1):e0208728. Disponible en: http://dx.doi.org/10.1371/journal.pone.0208728

  2. Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, et al. Ubrogepant for the treatment of migraine. N Engl J Med [Internet]. 2019 [citado el 15 abril 2023];381(23):2230–41. Disponible en: http://dx.doi.org/10.1056/nejmoa1813049

  3. Lipton RB, Munjal S, Alam A, Buse DC, Fanning KM, Reed ML, et al. Migraine in America Symptoms and treatment (MAST) study: Baseline study methods, treatment patterns, and gender differences. Headache [Internet]. 2018 [citado el 15 abril 2023];58(9):1408–26. Disponible en: http://dx.doi.org/10.1111/head.13407

  4. Raffaelli B, Neeb L, Reuter U. Monoclonal antibodies for the prevention of migraine. Expert Opin Biol Ther [Internet]. 2019 [citado el 19 abril 2023];19(12):1307–17. Disponible en: http://dx.doi.org/10.1080/14712598.2019.1671350

  5. Do TP, Remmers A, Schytz HW, Schankin C, Nelson SE, Obermann M, et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list: SNNOOP10 list. Neurology [Internet]. 2019 [citado el 19 abril 2023];92(3):134–44. Disponible en: http://dx.doi.org/10.1212/WNL.0000000000006697

  6. Robblee J, Grimsrud KW. Emergency department and inpatient management of headache in adults. Curr Neurol Neurosci Rep [Internet]. 2020 [citado el 19 abril 2023];20(4):7. Disponible en: http://dx.doi.org/10.1007/s11910-020-01030-w

  7. Steiner TJ, Jensen R, Katsarava Z, Linde M, MacGregor EA, Osipova V, et al. Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache: On behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache. J Headache Pain [Internet]. 2019 [citado el 19 abril 2023];20(1):57. Disponible en: http://dx.doi.org/10.1186/s10194-018-0899-2

  8. Starling AJ. Diagnosis and management of headache in older adults. Mayo Clin Proc [Internet]. 2018 [citado el 19 abril 2023];93(2):252–62. Disponible en: http://dx.doi.org/10.1016/j.mayocp.2017.12.002

  9. Do TP, la Cour Karottki NF, Ashina M. Updates in the diagnostic approach of headache. Curr Pain Headache Rep [Internet]. 2021 [citado el 19 abril 2023];25(12):80. Disponible en: http://dx.doi.org/10.1007/s11916-021-00995-8

  10. Pohl H. Red flags in headache care. Headache [Internet]. 2022 [citado el 19 abril 2023];62(4):534–5. Disponible en: http://dx.doi.org/10.1111/head.14273

  11. Conti R, Marta G, Wijers L, Barbi E, Poropat F. Red flags presented in children complaining of headache in pediatric emergency department. Children (Basel) [Internet]. 2023 [citado el 19 abril 2023];10(2). Disponible en: http://dx.doi.org/10.3390/children10020366

  12. Tzankova V, Becker WJ, Chan TLH. Diagnosis and acute management of migraine. CMAJ [Internet]. 2023 [citado el 19 abril 2023];195(4):E153–8. Disponible en: http://dx.doi.org/10.1503/cmaj.211969

  13. Ray JC, Hutton EJ. Imaging in headache disorders. Aust Prescr [Internet]. 2022 [citado el 19 abril 2023];45(3):88–92. Disponible en: http://dx.doi.org/10.18773/austprescr.2022.023

  14. Hadidchi S, Surento W, Lerner A, Liu C-SJ, Gibbs WN, Kim PE, et al. Headache and brain tumor. Neuroimaging Clin N Am [Internet]. 2019 [citado el 19 abril 2023];29(2):291–300. Disponible en: http://dx.doi.org/10.1016/j.nic.2019.01.008

  15. Young NP, Elrashidi MY, McKie PM, Ebbert JO. Neuroimaging utilization and findings in headache outpatients: Significance of red and yellow flags. Cephalalgia [Internet]. 2018 [citado el 19 abril 2023];38(12):1841–8. Disponible en: http://dx.doi.org/10.1177/0333102418758282




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Revista Médica Sinergia. 2023;8